Rilutek

Product manufactured by Covis Pharma

Application Nr Approved Date Route Status External Links
NDA020599 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rilutek Is Indicated For The Treatment Of Amyotrophic Lateral Sclerosis (Als). Rilutek Is Indicated For The Treatment Of Amyotrophic Lateral Sclerosis (Als) ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Riluzole RILUZOLE ZINC6481

Comments